Brain
-
Personalized TMS Shows Promise for Severe OCD in Singapore Study
NUH and NUS Medicine report early success using fMRI-guided stimulation for treatment-resistant OCD, aiming to extend the method to depression and anxiety.
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Selangor International Care Expo 2026 Targets the Growing Care Economy
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
START Opens First Italian Early-Phase Cancer Trial Site in Rome
-
Personalized TMS Shows Promise for Severe OCD in Singapore Study
-
Dhaka Shelter Gives 85 Cancer Patients Beds, Meals and Support
-
Researchers find biological clues to why colorectal cancer strikes young adults
-
Study Links Louisiana Industrial Pollution to Fourfold Rise in Infant Heart Defects
-
How a $310,000 Investment Gain Can Boost Medicare Premiums for Retirees
-
Inovio’s First FDA Approval Tests Whether DNA Medicines Can Pay Off for Retail Investors
-
High-Yield Savings Rates Reach 4.70% on November 3
-
UK Mortgage Market: 2.3 Million Households Face £3,600 Annual Repayment Jump as Fixed Deals Expire
-
Personal Factors Driving Cancer Biomarker Decisions and Patient Outcomes
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992